Canada markets closed

Entourage Health Corp. (ENTG.V)

TSXV - TSXV Real Time Price. Currency in CAD
Add to watchlist
0.0500-0.0050 (-9.09%)
At close: 03:59PM EDT
Full screen
Previous Close0.0550
Open0.0550
Bid0.0500 x N/A
Ask0.0550 x N/A
Day's Range0.0500 - 0.0550
52 Week Range0.0350 - 0.3100
Volume81,233
Avg. Volume117,326
Market Cap15.199M
Beta (5Y Monthly)1.46
PE Ratio (TTM)N/A
EPS (TTM)-0.2970
Earnings DateAug 08, 2022 - Aug 12, 2022
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target Est0.05
  • GlobeNewswire

    Entourage Health Announces $8.9 Million Upsize to Credit Facility and Implementation of Proposed Amendments to 8.5% Unsecured Convertible Debentures

    TORONTO, June 27, 2022 (GLOBE NEWSWIRE) -- Entourage Health Corp. (TSX-V:ENTG) (OTCQX:ETRGF) (FSE:4WE) (“Entourage” or the “Company”), a Canadian producer and distributor of award-winning cannabis products, announced today it has amended and upsized its existing credit facility (the “Credit Facility”) with an affiliate of the LiUNA Pension Fund of Central and Eastern Canada (“LPF”), adding an additional $8.9 million in non-dilutive funding availability (the “Credit Facility Amendments”). Net pro

  • GlobeNewswire

    Entourage Health Provides Update on Proposed Amendments to its 8.5% Unsecured Convertible Debentures

    TORONTO, June 21, 2022 (GLOBE NEWSWIRE) -- Entourage Health Corp. (TSX-V:ENTG) (OTCQX:ETRGF) (FSE:4WE) (“Entourage” or the “Company”), a Canadian producer and distributor of award-winning cannabis products, is pleased to provide an update on the previously announced proposed amendments (the “Proposed Amendments”) to the trust indenture dated as of September 25, 2019 between TSX Trust Company and the Company governing the Company’s 8.5% unsecured convertible debentures due September 25, 2022 (the

  • GlobeNewswire

    Entourage Health Announces Debentureholders Overwhelmingly Approve Proposed Amendments to 8.5% Unsecured Convertible Debentures

    Company confirms it is one of many positive steps being taken to improve debt position and streamline capital structure for long-term successTORONTO, June 20, 2022 (GLOBE NEWSWIRE) -- Entourage Health Corp. (TSX-V:ENTG) (OTCQX:ETRGF) (FSE:4WE) (“Entourage” or the “Company”), a Canadian producer and distributor of award-winning cannabis products, is pleased to announce that holders (the “Debentureholders”) of the Company’s 8.5% unsecured convertible debentures due September 25, 2022 (the “Debentu